Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $16.5300 (1.97%) ($16.0700 - $16.5300) on Tue. Mar. 9, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.72% (three month average) | RSI | 33 | Latest Price | $16.5300(1.97%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.7% a day on average for past five trading days. | Weekly Trend | ATRA declines -4.2% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -1.36% in a week (0% probabilities). VIXM(-34%) VXX(-27%) IGOV(-15%) UNG(-11%) TLT(-10%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.36% (StdDev 2.72%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $3.33(-79.85%) | Inflection Point | Yes | Resistance Level | $17.38 | 5 Day Moving Average | $16.11(2.61%) | 10 Day Moving Average | $16.51(0.12%) | 20 Day Moving Average | $17.38(-4.89%) | To recent high | -31.4% | To recent low | 4.6% | Market Cap | $1.228b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |